Combination drug regimens including PI are accompanied by impaired glucose tolerance, hyperproinsulinaemia as an indicator for beta-cell dysfunction, and lipid abnormalities proved to be significant risk factors for coronary heart disease. Moreover, PI may have an impact on the processing of proinsulin to insulin.

Coinfection with GBV-C is associated with a reduced mortality rate in HIV-infected patients. GBV-C is not known to cause any disease, but it is possible that its presence leads to an inhibition of HIV replication. However, GBV-C infection could also be a marker for the presence of other factors that lead to a favorable HIV response.

No abstract

Background: Elucidating the role of T cell responses in COVID-19 is of utmost importance to understand the clearance of SARS-CoV-2 infection. Methods: 30 hospitalized COVID-19 patients and 60 age-and gender-matched healthy controls (HC) participated in this study. We used two comprehensive 11-colour flow cytometric panels conforming to Good Laboratory Practice and approved for clinical diagnostics. Findings: Absolute numbers of lymphocyte subsets were differentially decreased in COVID-19 patients according to clinical severity. In severe disease (SD) patients, all lymphocyte subsets were reduced, whilst in mild disease (MD) NK, NKT and gd T cells were at the level of HC. Additionally, we provide evidence of T cell activation in MD but not SD, when compared to HC. Follow up samples revealed a marked increase in effector T cells and memory subsets in convalescing but not in non-convalescing patients. Interpretation: Our data suggest that activation and expansion of innate and adaptive lymphocytes play a major role in COVID-19. Additionally, recovery is associated with formation of T cell memory as suggested by the missing formation of effector and central memory T cells in SD but not in MD. Understanding T cell-responses in the context of clinical severity might serve as foundation to overcome the lack of effective anti-viral immune response in severely affected COVID-19 patients and can offer prognostic value as biomarker for disease outcome and control.

Background. Human immunodeficiency virus (HIV)–infected individuals are at increased risk of herpes zoster (HZ), even in the antiretroviral therapy (ART) era. Because concerns exist about the use of live-attenuated vaccines in immunocompromised individuals, a subunit vaccine may be an appropriate alternative.Methods. This phase 1/2, randomized, placebo-controlled study evaluated the immunogenicity and safety of an investigational HZ subunit vaccine (HZ/su). Three cohorts of HIV-infected adults aged ≥18 years were enrolled: 94 ART recipients with a CD4+ T-cell count of ≥200 cells/mm3, 14 ART recipients with a CD4+ T-cell count of 50–199 cells/mm3, and 15 ART-naive adults with a CD4+ T-cell count of ≥500 cells/mm3. Subjects received 3 doses of HZ/su (50 µg varicella-zoster virus glycoprotein E [gE] combined with AS01B adjuvant) or 3 doses of saline at months 0, 2, and 6.Results. One month after dose 3, serum anti-gE antibody concentrations and frequencies of gE-specific CD4+ T cells were higher following HZ/su vaccination than after receipt of saline (P < .0001). Median cell-mediated immune responses peaked after dose 2. Humoral and cell-mediated immune responses persisted until the end of the study (month 18). No vaccination-related serious adverse events were reported. No sustained impact on HIV load or CD4+ T-cell count was noted following vaccinations.Conclusions. HZ/su was immunogenic and had a clinically acceptable safety profile in HIV-infected adults.Clinical Trials Registration. NCT01165203.

DNA sequence data from the internal transcribed spacer (ITS) region of the nuclear rDNA genes were used to determine a phylogenetic relationship between the graminicolous smut genera Ustilago and Sporisorium (Ustilaginales). Fifty-three members of both genera were analysed together with three related outgroup genera. Neighbor-joining and Bayesian inferences of phylogeny indicate the monophyly of a bipartite genus Sporisorium and the monophyly of a core Ustilago clade. Both methods confirm the recently published nomenclatural change of the cane smut Ustilago scitaminea to Sporisorium scitamineum and indicate a putative connection between Ustilago maydis and Sporisorium. Overall, the three clades resolved in our analyses are only weakly supported by morphological characters. Still, their preferences to parasitize certain subfamilies of Poaceae could be used to corroborate our results: all members of both Sporisorium groups occur exclusively on the grass subfamily Panicoideae. The core Ustilago group mainly infects the subfamilies Pooideae or Chloridoideae.Key words: basidiomycete systematics, ITS, molecular phylogeny, Bayesian analysis, Ustilaginomycetes, smut fungi.Résumé : Afin de déterminer la relation phylogénétique des genres Ustilago et Sporisorium (Ustilaginales), responsables du charbon chez les graminées, les auteurs ont utilisé les données de séquence de la région espaceur transcrit interne (ITS) des gènes nucléiques ADNr. Ils ont analysé 53 membres de ces genres, ainsi que trois genres apparentés. Les liens avec les voisins et l'inférence bayésienne de la phylogénie indiquent la monophylie d'un genre Sporisorium bipartite et la monophylie d'un clade Ustilago central. Les deux méthodes confirment le changement de nomenclature récemment publié faisant passer le charbon du roseau d'Ustilago scitaminea à Sporisorium scitamineum, et indiquent un lien possible entre l'Ustilago maydis et le genre Sporisorium. Dans l'ensemble, les trois clades résolus dans ces analyses ne sont que faiblement supportés par des caractères morphologiques. Tout de même, leurs préférences comme parasites de certaines familles de Poaceae pourraient être utilisées pour corroborer les résultats obtenus : tous les membres des deux groupes de Sporisorium se retrouvent exclusivement dans la sous-famille Panicoideae. Le groupe central Ustilago infecte les sous-familles Pooideae ou Chloridoideae.

To investigate a possible influence of GB virus C (GBV-C) in immunocompromised patients, the prevalences of GBV-C RNA and anti-E2 antibody in 197 human immunodeficiency virus (HIV)-infected patients and in 120 control blood donors were studied. GBV-C RNA was detected in 33 of 197 HIV-infected patients (16.8%) compared with 1 in 120 blood donors (0.8%) (P < .001). Previous exposure to GBV-C (anti-E2 antibody-positive) was shown in 56.8% of HIV patients and in 9% of blood donors. GBV-C viremia was not associated with hepatitis. Despite approximately equal duration of HIV infection in all subgroups, the CD4 cell counts were significantly higher in GBV-C-viremic patients (344 cells/microL) compared with exposed (259 cells/microL) and unexposed (170 cells/microL) patients (P = .017 and P < .001). Furthermore, Kaplan-Meier analysis demonstrated significantly better cumulative survival in GBV-C RNA-positive HIV-infected patients, suggesting that GBV-C might be a favorable prognostic factor in HIV disease.

No abstract